Perlecan (HSPG2) promotes structural, contractile, and metabolic development of human cardiomyocytes.



Johnson, Benjamin B, Cosson, Marie-Victoire, Tsansizi, Lorenza I, Holmes, Terri L, Gilmore, Tegan, Hampton, Katherine, Song, Ok-Ryul, Vo, Nguyen TN, Nasir, Aishah, Chabronova, Alzbeta ORCID: 0000-0002-9733-444X
et al (show 8 more authors) (2024) Perlecan (HSPG2) promotes structural, contractile, and metabolic development of human cardiomyocytes. Cell reports, 43 (1). p. 113668. ISSN 2211-1247, 2211-1247

[thumbnail of Perlecan Manuscript_Resubmission_Finalize(1).docx] Microsoft Word (OpenXML)
Perlecan Manuscript_Resubmission_Finalize(1).docx - Author Accepted Manuscript

Download (296kB)

Abstract

Perlecan (HSPG2), a heparan sulfate proteoglycan similar to agrin, is key for extracellular matrix (ECM) maturation and stabilization. Although crucial for cardiac development, its role remains elusive. We show that perlecan expression increases as cardiomyocytes mature in vivo and during human pluripotent stem cell differentiation to cardiomyocytes (hPSC-CMs). Perlecan-haploinsuffient hPSCs (HSPG2+/-) differentiate efficiently, but late-stage CMs have structural, contractile, metabolic, and ECM gene dysregulation. In keeping with this, late-stage HSPG2+/- hPSC-CMs have immature features, including reduced ⍺-actinin expression and increased glycolytic metabolism and proliferation. Moreover, perlecan-haploinsuffient engineered heart tissues have reduced tissue thickness and force generation. Conversely, hPSC-CMs grown on a perlecan-peptide substrate are enlarged and display increased nucleation, typical of hypertrophic growth. Together, perlecan appears to play the opposite role of agrin, promoting cellular maturation rather than hyperplasia and proliferation. Perlecan signaling is likely mediated via its binding to the dystroglycan complex. Targeting perlecan-dependent signaling may help reverse the phenotypic switch common to heart failure.

Item Type: Article
Uncontrolled Keywords: Extracellular Matrix, Myocytes, Cardiac, Humans, Agrin, Extracellular Matrix Proteins, Heparan Sulfate Proteoglycans
Divisions: Faculty of Health & Life Sciences
Faculty of Health & Life Sciences > Inst. Life Courses & Medical Sciences
Depositing User: Symplectic Admin
Date Deposited: 03 Jun 2024 09:32
Last Modified: 23 May 2026 08:21
DOI: 10.1016/j.celrep.2023.113668
Related Websites:
URI: https://livrepository.liverpool.ac.uk/id/eprint/3181901
Disclaimer: The University of Liverpool is not responsible for content contained on other websites from links within repository metadata. Please contact us if you notice anything that appears incorrect or inappropriate.